Sun Pharmaceuticals

Sun Pharma in talks to buy Novartis’ Japan portfolio

14 Nov 2015

ICRA gives triple-A ratings to Sun’s borrowing plans

14 Nov 2015

Sun Pharma completes acquisition of InSite Vision

03 Nov 2015

US FDA rescinds approval for Sun Pharma's epilepsy drug Elepsia XR

26 Sep 2015

The US Food and Drug Administration (US FDA) has revoked an earlier approval to Sun Pharma Advanced Research Company Ltd to market its new drug for seizures

Sun Pharma sells two Ranbaxy units to Strides Arcolab

21 Sep 2015

Sun Pharma to acquire US firm InSite Vision for $48 mn

18 Sep 2015

Sun Pharma shows the door to 18 senior Ranbaxy Labs executives

18 Jun 2015

Daiichi Sankyo sells entire 9% stake in Sun Pharma for Rs20,420 cr

21 Apr 2015

Daiichi Sankyo said it would make an announcement concerning gains or losses on the sale of Sun Pharma shares when results of operations for the fiscal year ending in March 2015 are announced

Daiichi Sankyo begins selling its stake in Sun Pharma

21 Apr 2015

Sun, Ranbaxy complete $4-bn merger

24 Mar 2015

On Tuesday, the Reserve Bank of India approved the issue of equity shares of Sun Pharma to non-resident holders of equity shares of Ranbaxy, facilitating the merger through a scheme of arrangement

Sun-Ranbaxy merger deal nears closure with HC nod

09 Mar 2015

Sun Pharma’s Dilip Shanghvi pips Mukesh Ambani to become richest Indian

05 Mar 2015

Dilip Shanghvi, who is also the world’s richest pharmaceutical billionaire, added $4.5 billion to his fortune this year, making him fourth-wealthiest in Asia and 37th in the world

Sun Pharma to buy Glaxo’s Australian opiates business

03 Mar 2015

The deal comes as Sun wraps up the last leg of its $ 4-billion proposal to buy troubled generic drugs maker Ranbaxy in India

Suzlon Energy confirms 23% stake sale to Sun’s Shanghvi

14 Feb 2015

Dilip Shanghvi and others on Saturday made an open offer to shareholders of Suzlon Energy immediately after announcing that it would invest Rs1,800 crore in the company

Sun’s Shanghvi reported in talks with Tanti for Suzlon stake

13 Feb 2015

Sun Pharmaceuticals founder Dilip Shanghvi and Tulsi Tanti of Suzlon Energy are in advanced talks for a multi-layer deal to eventually give the pharma baron's family a stake in the debt-laden wind turbine maker

Sun Pharma buyout of Ranbaxy gets conditional US nod

31 Jan 2015

Fearing that the $4-billion deal would be anti-competitive, the FTC has stipulated that Sun sell its interest in a generic anti-bacterial medicine

Sun Pharma, Ranbaxy merger deal gets conditional CCI nod

09 Dec 2014

The CCI has asked the two companies to sell off seven brands with combined sales of less than Rs50 crore and market share of 60 to 80 per cent, which the regulator felt, would adversely affect competition

Sun Pharma hopes to turn around Ranbaxy in four years of closing deal

12 Sep 2014

Competition panel seeks public comments on Sun-Ranbaxy merger deal

04 Sep 2014

CCI worried about ‘molecular’ effect of Sun-Ranbaxy merger

30 Aug 2014

Sun-Ranbaxy merger: competition panel demands more details

28 Aug 2014

This is probably the first instance where the fair trade watchdog has ordered a public scrutiny of a proposed merger and acquisition deal to ensure compliance to fair trade regulation

Sun Pharma unit recalls Cephalexin capsules in US market

16 Aug 2014

After Ranbaxy acquisition, Sun Pharma set to own Pharmalucence of US

16 Jul 2014

AP High Court vacates stay on Ranbaxy-Sun Pharma merger

24 May 2014

The Andhra Pradesh High Court has vacated a stay on the proposed merger of Ranbaxy Laboratories with Sun Pharma over alleged insider trading in Ranbaxy shares ahead of the merger announcement

US FDA warns Sun Pharma over manufacturing practices at Karkhadi plant

22 May 2014

View details about the software product Informachine News Trackers